Recertification is Just Around the Corner
The 340B annual recertification period for HRSA grantees will be from February 7, 2018 to March 7, 2018. Recertification must be completed through the new 340B Office of Pharmacy Affairs…
New England Journal of Medicine Presents Distorted View of 340B Program
On January 24th, the New England Journal of Medicine (“NEJM”) published a study linking the 340B program to an increase in hospital-physician consolidation in the specialties of hematology-oncology and suggesting…
Hatch Suggests CMS Should Administer 340B Program
On January 26th, Senate Finance Committee Chairman Orrin Hatch sent a letter to the incoming Secretary of HHS, Alex Azar, asking several questions about his plans to work with HRSA…
HRSA Revises Its Audit Policies
HRSA recently added language to its written policies on covered entity audits which suggests that the agency may conduct more follow-up audits. Those follow-up audits could result in tougher sanctions,…
Legislation Mispresents Purpose of 340B Program, Threatens all Covered Entities
“Recently introduced legislation purporting to reform the 340B program is a wolf in sheep’s clothing,” said Sara J. Dingwall, Pharm.D, BCPS, AAHIVP, President of RWC-340B and Pharmacy Director of an…
House E&C Committee Issues Report on 340B Program
The House Energy and Commerce (E&C) Committee released a report today entitled “Review of the 340B Drug Pricing Program.” The report covers a wide range of topics under the 340B…